The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates

Haiyan Yang1, Guangcai Duan, Jingyuan Zhu

  • 1Department of Epidemiology, College of Public Health of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.

Microbial Drug Resistance (Larchmont, N.Y.)
|November 28, 2008
PubMed

Insights

Overexpression of the acrA gene contributes to multiple-antibiotic resistance (Mar) in Shigella flexneri. Efflux pump inhibitors showed potential in restoring ciprofloxacin susceptibility in resistant strains.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Shigella flexneri is a significant cause of bacterial dysentery.
  • Multiple-antibiotic resistance (Mar) in bacterial pathogens poses a global health threat.
  • The AcrAB-TolC efflux pump system is crucial for multidrug resistance in many Gram-negative bacteria.

Purpose of the Study:

  • To investigate the role of the AcrAB-TolC efflux pump in the multiple-antibiotic resistance (Mar) of Shigella flexneri clinical isolates.
  • To identify genetic mutations associated with Mar phenotypes in Shigella flexneri.
  • To evaluate the efficacy of efflux pump inhibition in overcoming antibiotic resistance.

Main Methods:

  • Characterization of Mar and susceptible Shigella flexneri isolates.
  • Quantitative PCR and Northern blot analysis to determine acrAB-tolC gene expression levels.
  • DNA sequencing of acrAB-tolC genes in selected isolates.
  • Ciprofloxacin accumulation assays and efflux inhibition studies using Phe-Arg-beta-naphthylamide.

Main Results:

  • Ciprofloxacin accumulation was significantly lower in Mar isolates compared to susceptible isolates.
  • The expression of acrA mRNA was significantly higher in Mar isolates.
  • Specific mutations in acrA and tolC genes were identified in resistant and susceptible strains, respectively.
  • Efflux pump inhibitors demonstrated efficacy in restoring ciprofloxacin susceptibility in some Mar isolates.

Conclusions:

  • Overexpression of the acrA gene is a key mechanism driving Mar in clinical Shigella flexneri isolates.
  • Acquired resistance to ciprofloxacin can be reversed using efflux pump inhibitors like Phe-Arg-beta-naphthylamide.
  • The AcrAB-TolC efflux pump system represents a potential therapeutic target for combating antibiotic resistance in Shigella flexneri.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...